CAPSONI, Simona
 Distribuzione geografica
Continente #
NA - Nord America 8.722
AS - Asia 4.208
EU - Europa 1.946
SA - Sud America 666
AF - Africa 114
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 2
Totale 15.678
Nazione #
US - Stati Uniti d'America 8.597
SG - Singapore 1.676
CN - Cina 861
BR - Brasile 517
VN - Vietnam 447
IT - Italia 403
HK - Hong Kong 367
TR - Turchia 301
DE - Germania 272
UA - Ucraina 261
GB - Regno Unito 212
PL - Polonia 184
SE - Svezia 139
JP - Giappone 137
FR - Francia 131
FI - Finlandia 119
RU - Federazione Russa 105
IN - India 96
MX - Messico 71
ID - Indonesia 65
BD - Bangladesh 58
AR - Argentina 48
IQ - Iraq 45
ZA - Sudafrica 45
CA - Canada 41
NL - Olanda 30
EC - Ecuador 25
PH - Filippine 22
CO - Colombia 20
AU - Australia 18
ES - Italia 18
VE - Venezuela 17
PK - Pakistan 16
UZ - Uzbekistan 15
MY - Malesia 14
TN - Tunisia 13
AT - Austria 12
KR - Corea 12
MA - Marocco 12
CL - Cile 11
KE - Kenya 11
SA - Arabia Saudita 11
PY - Paraguay 9
CZ - Repubblica Ceca 8
LT - Lituania 8
AE - Emirati Arabi Uniti 7
AL - Albania 7
AZ - Azerbaigian 6
BO - Bolivia 6
EG - Egitto 6
KZ - Kazakistan 6
SD - Sudan 6
UY - Uruguay 6
BE - Belgio 5
DZ - Algeria 5
IE - Irlanda 5
IL - Israele 5
IR - Iran 5
NP - Nepal 4
OM - Oman 4
PE - Perù 4
TH - Thailandia 4
BG - Bulgaria 3
GY - Guiana 3
JM - Giamaica 3
JO - Giordania 3
PS - Palestinian Territory 3
PT - Portogallo 3
RO - Romania 3
CH - Svizzera 2
CR - Costa Rica 2
EE - Estonia 2
ET - Etiopia 2
GE - Georgia 2
GR - Grecia 2
KG - Kirghizistan 2
KH - Cambogia 2
KW - Kuwait 2
LY - Libia 2
NZ - Nuova Zelanda 2
QA - Qatar 2
RS - Serbia 2
SN - Senegal 2
TW - Taiwan 2
AO - Angola 1
BB - Barbados 1
BH - Bahrain 1
BJ - Benin 1
BT - Bhutan 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
CI - Costa d'Avorio 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EU - Europa 1
GD - Grenada 1
GH - Ghana 1
GT - Guatemala 1
HN - Honduras 1
Totale 15.658
Città #
Ashburn 1.032
Singapore 966
Fairfield 899
Woodbridge 794
Houston 600
San Jose 465
Ann Arbor 436
Chandler 418
Jacksonville 403
Hong Kong 360
Seattle 351
Santa Clara 334
Cambridge 301
Beijing 291
Wilmington 290
Warsaw 182
Izmir 171
Ho Chi Minh City 151
Tokyo 132
Milan 110
Hanoi 108
Los Angeles 108
Nanjing 108
Council Bluffs 104
Princeton 98
Boardman 96
Lauterbourg 96
Dallas 92
San Diego 73
New York 70
The Dalles 58
Ferrara 50
Jakarta 50
São Paulo 46
Dearborn 45
Chicago 43
Addison 41
Nanchang 41
Munich 39
Falls Church 38
Columbus 37
London 34
Mexico City 34
Rome 34
Boydton 31
Orem 31
Phoenix 28
Shenyang 27
Brooklyn 26
Hebei 26
Moscow 26
Shanghai 26
Des Moines 24
Tianjin 24
Chennai 23
Denver 23
Helsinki 23
Jiaxing 23
Mountain View 21
Rio de Janeiro 21
Atlanta 20
Haiphong 20
Johannesburg 20
Stockholm 20
Changsha 19
San Francisco 18
Bursa 17
Da Nang 17
Redwood City 17
Baghdad 15
Boston 15
Manchester 15
Nuremberg 15
Montreal 14
Mumbai 14
Norwalk 13
New Delhi 12
Belo Horizonte 11
Dong Ket 11
Guangzhou 11
Kunming 11
Poplar 11
Hefei 10
Perth 10
Tashkent 10
Cape Town 9
Frankfurt am Main 9
Medellín 9
Quito 9
Amsterdam 8
Ankara 8
Lahore 8
Lanzhou 8
Tappahannock 8
Toronto 8
Turku 8
Brasília 7
Bắc Ninh 7
Jinan 7
Kuala Lumpur 7
Totale 11.118
Nome #
NGF steers microglia toward a neuroprotective phenotype 318
Phenotypic knockout of nerve growth factor in adult transgenic mice reveals severe deficits in basal forebrain cholinergic neurons, cell death in the spleen and skeletal muscle dystrophy 310
Environmental enrichment delays the onset of memory deficits and reduces neuropathological hallmarks in a mouse model of Alzheimer-like neurodegeneration 239
Characterization of melatonin receptors and signal transduction system in rat arteries forming the circle of Willis 223
Amyloid plaque-independent deficit of early postnatal visual cortical plasticity in the 5xFAD transgenic model of Alzheimer's disease. 223
A small molecule targeting the multifactorial nature of Alzheimer's disease 219
Non-human transgenic animals for the study of neurodegenerative syndromes 217
Delivery of NGF to the brain: intranasal versus ocular administration in anti-NGF transgenic mice 217
Alzheimer-like neurodegeneration in aged antinerve Growth factor transgenic mice 216
Acute cholinergic rescue of synaptic plasticity in the neurodegenerating cortex of anti-nerve-growth-factor mice 214
Dark rearing blocks the developmental down-regulation of brain-derived neurotrophic factor messenger RNA expression in layers IV and V of the rat visual cortex 213
A dual mechanism linking NGF/ProNGF imbalance and early inflammation to Alzheimer's disease neurodegeneration in the AD11 anti-NGF mouse model 213
Autoradiographic localization of putative melatonin receptors in the brains of two old world primates: Cercopithecus aethiops and Papio ursinus 210
A carnivore species (Canis familiaris) expresses circadian melatonin rhythm in the peripheral blood and melatonin receptors in the brain 202
The chemokine CXCL12 mediates the anti-amyloidogenic action of painless human nerve growth factor 202
Taking pain out of NGF: a "painless" NGF mutant, linked to hereditary sensory autonomic neuropathy type V, with full neurotrophic activity 201
Understanding pain perception through genetic painlessness diseases: The role of NGF and proNGF 199
2-Bromomelatonin: synthesis and characterization of a potent melatonin agonist 194
Gene expression biomarkers in the brain of a mouse model for Alzheimer's disease: Mining of microarray data by logic classification and feature selection 188
ProNGF\NGF imbalance triggers learning and memory deficits, neurodegeneration and spontaneous epileptic-like discharges in transgenic mice 188
Nerve growth factor and galantamine ameliorate early signs of neurodegeneration in anti-nerve growth factor mice 185
Electrophysiological and behavioral effect of ozone on mice olfactory bulb 176
Functional Characterization of Human ProNGF and NGF Mutants: Identification of NGF P61SR100E as a "Painless" Lead Investigational Candidate for Therapeutic Applications 174
Beta-amyloid plaques in a model for sporadic Alzheimer's disease based on transgenic anti-nerve growth factor antibodies 174
Neutralization of Nerve Growth Factor impairs proliferation and differentiation of adult neural progenitors in the subventricular zone 174
Pathogen-Free Husbandry Conditions Alleviate Behavioral Deficits and Neurodegeneration in AD10 Anti-NGF Mice. 172
Intranasal "painless" human nerve growth factors slows amyloid neurodegeneration and prevents memory deficits in app x PS1 mice 171
Dissecting the involvement of tropomyosin-related kinase A and p75 neurotrophin receptor signaling in NGF deficit-induced neurodegeneration 170
ProNGF drives localized and cell selective parvalbumin interneuron and perineuronal net depletion in the dentate gyrus of transgenic mice 169
On the molecular basis linking Nerve Growth Factor (NGF) to Alzheimer’s disease 168
SorLA Deficiency Dissects Amyloid Pathology from Tau and Cholinergic Neurodegeneration in a Mouse Model of Alzheimer's Disease 168
Transgenic mice with chronic NGF deprivation and Alzheimer's disease-like pathology display hippocampal region-specific impairments in short- and long-term plasticities 166
Abeta-dependent Inhibition of LTP in different intracortical circuits of the visual cortex: the role of RAGE 163
Toxic properties of microsome-associated alpha-synuclein species in mouse primary neurons 163
Identification of a caspase-derived N-terminal tau fragment in cellular and animal Alzheimer's disease models 160
Cholinergic striatal neurons are increased in HSAN V homozygous mice despite reduced NGF bioavailability 160
Postnatal development of GFAP in mouse visual cortex is not affected by light deprivation 159
Time window in cholinomimetic ability to rescue long-term potentiation in neurodegenerating anti-nerve growth factor mice 159
The positional identity of mouse ES cell-generated neurons is affected by BMP signaling 158
Dissecting the role of sortilin receptor signaling in neurodegeneration induced by NGF deprivation 158
Failure of nicotine-dependent enhancement of synaptic efficacy at Schaffer-collateral CA1 synapses of AD11 anti-nerve growth factor transgenic mice 158
Intranasal delivery of therapeutic proteins for neurological diseases 156
Intranasal administration of nerve growth factor (NGF) rescues recognition memory deficits in AD11 anti-NGF transgenic mice 155
Antagonization of NGF in adult mice by transgenic antibodies causes progressive learning and memory impairments 154
Early inflammation and immune response mRNAs in the brain of AD11 anti-NGF mice 153
Nerve growth factor regulates axial rotation during early stages of chick embryo development 152
Localization and characterization of melatonin binding sites in the brain of the rabbit (Oryctolagus cuniculus) by autoradiography and in vitro ligand-receptor binding 152
A Microglial Function for the Nerve Growth Factor: Predictions of the Unpredictable 151
In vitro receptor binding properties of a "painless" NGF mutein, linked to hereditary sensory autonomic neuropathy type V 151
Nerve growth factor scales endocannabinoid signaling by regulating monoacylglycerol lipase turnover in developing cholinergic neurons 150
Functional blockade of tyrosine kinase A in the rat basal forebrain by a novel antagonistic anti-receptor monoclonal antibody 150
Towards non invasive nerve growth factor therapies for Alzheimer's disease 150
Characterization of endothelinA receptors in cerebral and peripheral arteries of the rat 150
Reduction of regional cerebral blood flow by melatonin in young rats 149
Rat visual cortical neurones express TrkA NGF receptor 148
Effects of the cholinesterase inhibitor galantamine in a mouse model of Alzheimer's disease, the anti-nerve growth factor AD11 transgenic mice 147
Ganstigmine and donepezil improve neurodegeneration in AD11 antinerve growth factor transgenic mice 145
Differential regulation of brain-derived neurotrophic factor messenger RNA cellular expression in the adult rat visual cortex 145
Melatonin signal transduction and mechanism of action in the central nervous system: Using the rabbit cortex as a model 144
Development of a non invasive NGF-based therapy for Alzheimer's disease 144
In the adult hippocampus, chronic nerve growth factor deprivation shifts GABAergic signaling from the hyperpolarizing to the depolarizing direction 144
Mismatch between BDNF mRNA and protein expression in the developing visual cortex: the role of visual experience 142
Endogenous A beta causes cell death via early tau hyperphosphorylation 141
Painless Nerve Growth Factor: A TrkA biased agonist mediating a broad neuroprotection via its actions on microglia cells 141
Pathogen free conditions slow the onset of neurodegeneration in a mouse model of nerve growth factor deprivation 140
Peripheral Neutralization of Nerve Growth Factor Induces Immunosympathectomy and Central Neurodegeneration in Transgenic Mice 140
From genes to pain: nerve growth factor and hereditary sensory and autonomic neuropathy type V 140
Muscular dystrophy in adult and aged anti-NGF transgenic mice resembles an inclusion body myopathy 135
Graphene Promotes Axon Elongation through Local Stall of Nerve Growth Factor Signaling Endosomes 133
Distribution and characterization of the melatonin receptors in the hypothalamus and pituitary gland of three domestic ungulates 132
Non-human transgenic animals for the study of neurodegenerative syndromes 130
Characterization by Gene Expression Analysis of Two Groups of Dopaminergic Cells Isolated from the Mouse Olfactory Bulb 130
The retina as a window to early dysfunctions of Alzheimer's disease following studies with a 5xFAD mouse model 129
Long-term memantine treatment prevents behavioral deficits in a mouse model of sporadic Alzheimer's disease 127
Rescue of the neurodegenerative phenotype in AD11 anti-NGF mice 122
The NGFR100W Mutation Specifically Impairs Nociception without Affecting Cognitive Performance in a Mouse Model of Hereditary Sensory and Autonomic Neuropathy Type V 121
Nerve Growth Factor regulates astrocyte physiology in vivo 121
Intranasal delivery of BDNF rescues memory deficits in AD11 mice and reduces brain microgliosis 119
Interaction between NH2-tau fragment and Aß in AD mitochondria contributes to the synaptic deterioration 118
Receptor for advanced glycation end product-dependent activation of p38 mitogen-activated protein kinase contributes to amyloid-beta-mediated cortical synaptic dysfunction 118
INIBITORE DI TNF ALPHA ASTROCITARIO PER L’USO NEL TRATTAMENTO DI MALATTIE NEUROLOGICHE 114
Alzheimer-like neurodegeneration in aged anti-nerve growth factor mice 113
Distribution and pharmacological characterization of melatonin receptors in the brain of the Japanese quail (Coturnix japonica) 111
Involvement of Bradykinin Receptor 2 in Nerve Growth Factor Neuroprotective Activity 110
Memoquin: A new therapeutic poly-agent for Alzheimer's disease 109
Muteins of hNGF, therapeutic uses and pharmaceutical compositions 107
Vasoactive intestinal peptide-like immunoreactive fibers in the pineal gland of the sheep 106
A p75 neurotrophin receptor‐sparing nerve growth factor protects retinal ganglion cells from neurodegeneration by targeting microglia 103
null 100
Unraveling the Role of Dopaminergic and Calretinin Interneurons in the Olfactory Bulb 99
Expression of the melatonin receptor in Xenopus laevis: A comparative study between protein and mRNA distribution 97
Nerve Growth Factor Neutralization Promotes Oligodendrogenesis by Increasing miR-219a-5p Levels 96
Acute cholinergic rescue of synaptic plasticity in the neurodegenerating cortex of anti-nerve growth factor mice 94
Inhibitor of astrocyte TNF alpha for use in the treatment of neurological diseases 93
Enteric Alpha-Synuclein Inclusions, Colonic Inflammation, Increased Mucosal Permeability and Alterations of Bowel Neuromuscular Functions Precede Central Neurodegeneration in a Transgenic Mouse Model of Parkinson's Disease 93
null 89
Reversal of neurological deficits by painless nerve growth factor in a mouse model of Rett syndrome 87
Taking pain out of NGF: a "painless" NGF mutant with full neurotrophic activity 83
Getting Into the Brain: The Intranasal Approach to Enhance the Delivery of Nerve Growth Factor and Its Painless Derivative in Alzheimer’s Disease and Down Syndrome 82
Reduced levels of NGF shift astrocytes toward a neurotoxic phenotype 75
Totale 15.341
Categoria #
all - tutte 69.850
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 69.850


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021452 0 0 0 0 0 0 0 0 0 200 161 91
2021/2022954 48 119 84 33 39 40 61 62 31 81 84 272
2022/20231.036 141 60 12 134 158 124 121 86 123 9 50 18
2023/2024471 53 66 19 20 24 41 10 31 3 32 16 156
2024/20252.158 28 52 171 67 271 167 73 168 314 265 368 214
2025/20265.558 480 296 590 700 797 310 902 307 555 621 0 0
Totale 15.921